Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BioStocks Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::112872946.png) Bio Stocks™ [@BioStocks](/creator/twitter/BioStocks) on x 68.6K followers
Created: 2025-07-22 12:01:17 UTC

$ATYR Announces Last Patient Visit in Phase X EFZO-FIT Study of Efzofitimod in Patients with Pulmonary Sarcoidosis.

Topline Data Q3 🔥


XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947628012339335214/c:line.svg)

**Related Topics**
[$atyr](/topic/$atyr)
[stocks](/topic/stocks)

[Post Link](https://x.com/BioStocks/status/1947628012339335214)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BioStocks Avatar Bio Stocks™ @BioStocks on x 68.6K followers Created: 2025-07-22 12:01:17 UTC

$ATYR Announces Last Patient Visit in Phase X EFZO-FIT Study of Efzofitimod in Patients with Pulmonary Sarcoidosis.

Topline Data Q3 🔥

XXXXXX engagements

Engagements Line Chart

Related Topics $atyr stocks

Post Link

post/tweet::1947628012339335214
/post/tweet::1947628012339335214